By Elsa Ohlen
Drugstore chain Walgreens Boots Alliance is nearing a deal to be bought by private-equity firm Sycamore for roughly $10 billion, a report says.
Walgreens stock rose 6.6% to $10.94 in premarket trading.
A deal price of between $11.30 and $11.40 a share in cash has been discussed and a deal could be reached as soon as Thursday, The Wall Street Journal reported late Monday, citing people familiar with the matter.
Walgreens didn't immediately respond to a request for comment early on Tuesday.
If Sycamore ends up completing the buyout it is expected to maintain the Walgreens U.S. retail business but sell or take public the remaining parts of the company, according to The Wall Street Journal.
Walgreens shares are down 51% over the last 12 months. The stock peaked a decade ago with a market value of more than $100 billion.
Write to Elsa Ohlen at elsa.ohlen@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 04, 2025 05:26 ET (10:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.